Diabetes Monitor - orlistat (Xenical)
Summarizes rationale of Roche's application to acquire indication for Xenical as adjunct therapy for people with type 2 diabetes.
These web site links are listed as a convenience to our visitors. If you use these links, we take no responsibility and give no guarantees, warranties or representations, implied or otherwise, for the content or accuracy of these third-party sites.
